Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression

por Baretton, G B, Klenk, U, Diebold, J, Schmeller, N, Löhrs, U
Publicado 1999

Rapid induction of p21(WAF1) but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells

por Kang, S H, Bang, Y-J, Jong, H-S, Seo, J Y, Kim, N K, Kim, S-J
Publicado 1999

Microsatellite instability, Epstein–Barr virus, mutation of type II transforming growth factor β receptor and BAX in gastric carcinomas in Hong Kong Chinese

por Leung, S Y, Yuen, S T, Chung, L P, Chu, K M, Wong, M P, Branicki, F J, Ho, J C I
Publicado 1999

Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells

por Okada, F, Nakai, K, Kobayashi, T, Shibata, T, Tagami, S, Kawakami, Y, Kitazawa, T, Kominami, R, Yoshimura, S, Suzuki, K, Taniguchi, N, Inanami, O, Kuwabara, M, Kishida, H, Nakae, D, Konishi, Y, Moriuchi, T, Hosokawa, M
Publicado 1999

Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line

por Hu, X F, Slater, A, Rischin, D, Kantharidis, P, Parkin, J D, Zalcberg, J
Publicado 1999

Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG)

por Kuin, A, Aalders, M, Lamfers, M, Zuidam, D J van, Essers, M, Beijnen, J H, Smets, L A
Publicado 1999

Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification

por Baars, J W, Jong, D de, Willemse, E M, Gras, L, Dalesio, O, Heerde, P v, Huygens, P C, Lelie, H v d, Borne, A E G Kr v.d.
Publicado 1999

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

por Culig, Z, Hoffmann, J, Erdel, M, Eder, I E, Hobisch, A, Hittmair, A, Bartsch, G, Utermann, G, Schneider, M R, Parczyk, K, Klocker, H
Publicado 1999

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients

por Werle, B, Lötterle, H, Schanzenbächer, U, Lah, T T, Kalman, E, Kayser, K, Bülzebruck, H, Schirren, J, Krasovec, M, Kos, J, Spiess, E
Publicado 1999

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 tria...

por Viens, P, Palangié, T, Janvier, M, Fabbro, M, Roché, H, Delozier, T, Labat, J P, Linassier, C, Audhuy, B, Feuilhade, F, Costa, B, Delva, R, Cure, H, Rousseau, F, Guillot, A, Mousseau, M, Ferrero, J M, Bardou, V J, Jacquemier, J, Pouillart, P
Publicado 1999

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination

por Yu, H, Levesque, M A, Clark, G M, Diamandis, E P
Publicado 1999

Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients

por Kuczyk, M, Machtens, S, Hradil, K, Schubach, J, Christian, W, Knüchel, R, Hartmann, J, Bokemeyer, C, Jonas, U, Serth, J
Publicado 1999

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymp...

por Schmidt-Wolf, I G H, Finke, S, Trojaneck, B, Denkena, A, Lefterova, P, Schwella, N, Heuft, H-G, Prange, G, Korte, M, Takeya, M, Dorbic, T, Neubauer, A, Wittig, B, Huhn, D
Publicado 1999

Schedule-dependent cytotoxicity of SN-38 in p53 wild-type and mutant colon adenocarcinoma cell lines

por Poele, R H te, Joel, S P
Publicado 1999

Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin

por O’Neill, C F, Koberle, B, Masters, J R W, Kelland, L R
Publicado 1999

Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat

por Xie, B, Tam, N N C, Tsao, S W, Wong, Y C
Publicado 1999

Characterization of the model for experimental testicular teratoma in 129/SvJ-mice

por Sundström, J, Pelliniemi, L J, Kuopio, T, Veräjänkorva, E, Fröjdman, K, Harley, V, Salminen, E, Pöllänen, P
Publicado 1999

A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay

por Raymond, E, Sun, D, Izbicka, E, Mangold, G, Silvas, E, Windle, B, Sharma, S, Soda, H, Laurence, R, Davidson, K, Hoff, D D Von
Publicado 1999

Oral topotecan: bioavailability and effect of food co-administration

por Herben, V M M, Rosing, H, Huinink, W W ten Bokkel, Zomeren, D M van, Batchelor, D, Doyle, E, Beusenberg, F D, Beijnen, J H, Schellens, J H M
Publicado 1999

PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma

por Simon, C, Hicks, M J, Nemechek, A J, Mehta, R, Jr, B W O'Malley, Goepfert, H, Flaitz, C M, Boyd, D
Publicado 1999